Phase I experience with emetine hydrochloride (NSC 33669) as an antitumor agent
- 1 April 1971
- Vol. 27 (4) , 835-841
- https://doi.org/10.1002/1097-0142(197104)27:4<835::aid-cncr2820270413>3.0.co;2-k
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Emetine myopathyNeurology, 1970
- Inhibitors of Protein BiosynthesisJournal of Biological Chemistry, 1968
- STRUCTURAL BASIS FOR INHIBITION OF PROTEIN SYNTHESIS BY EMETINE AND CYCLOHEXIMIDE BASED ON AN ANALOGY BETWEEN IPECAC ALKALOIDS AND GLUTARIMIDE ANTIBIOTICSProceedings of the National Academy of Sciences, 1966
- A New Pharmacological Action of EmetineBMJ, 1966
- Emetine in Treatment of Severe Septic StatesBMJ, 1964
- Emetine Toxicity with Predominant Neuromuscular ManifestationsPostgraduate Medical Journal, 1962
- EMETINE TOXICITY IN MAN: STUDIES ON THE NATURE OF EARLY TOXIC MANIFESTATIONS, THEIR RELATION TO THE DOSE LEVEL, AND THEIR SIGNIFICANCE IN DETERMINING SAFE DOSAGEAnnals of Internal Medicine, 1948
- Effects of emetine on the electrocardiogramAmerican Heart Journal, 1944
- Amoebic Dysentery and its Effective TreatmentBMJ, 1941
- ACTION OF EMETIN ON MALIGNANT TUMORSPublished by American Medical Association (AMA) ,1918